Task: Answer the multiple-choice question.
Question: Which compound exhibits a 3.391% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a: CCC(C)NC(=O)CN1C(=O)NC2(CCc3ccccc3C2)C1=O
b: C#CCN(CC=C)C(=O)C1CCC(=O)N(CCCc2ccccc2)C1
Answer: b. C#CCN(CC=C)C(=O)C1CCC(=O)N(CCCc2ccccc2)C1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
C#CCN(CC=C)C(=O)C1CCC(=O)N(CCCc2ccccc2)C1
C#CCN(CC=C)C(=O)C1CCC(=O)N(CCCc2ccccc2)C1
6-oxo-1-(3-phenylpropyl)-N-prop-2-enyl-N-prop-2-ynylpiperidine-3-carboxamide